Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 8/20 | 1.00 |
| ▸ | CA2 | P00918 | 6/20 | 1.00 |
| ▸ | CA9 | Q16790 | 5/20 | 1.00 |
| ▸ | CA1 | P00915 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 0.71 |
| ▸ | MEN1 | O00255 | 3/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.71 |
| ▸ | RECQL | P46063 | 2/20 | 0.71 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.71 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | MAPT | P10636 | 3/20 | 0.67 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.67 |
| ▸ | ESR1 | P03372 | 3/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5165243 | 1.00 | STS (1.00) | STSCA2CA9CA1LMNA | |
| SCHEMBL452224 | 0.91 | STS (0.83) | STSCA2CA9CA1LMNA | |
| SCHEMBL454879 | 0.91 | STS (0.83) | STSCA2CA9CA1LMNA | |
| Potassium Ion SCHEMBL28302250 | 0.90 | STS (0.81) | STSCA2CA9CA1LMNA | |
| SCHEMBL1317754 | 0.90 | STS (0.81) | STSCA2CA9CA1LMNA | |
| SCHEMBL6437576 | 0.90 | STS (0.81) | STSCA2CA9CA1LMNA | |
| SCHEMBL1316422 | 0.90 | STS (0.81) | STSCA2CA9CA1LMNA | |
| SCHEMBL12609016 | 0.90 | STS (0.81) | STSCA2CA9CA1LMNA | |
| SCHEMBL5167329 | 0.89 | STS (1.00) | STSCA2CA9CA1CYP3A4 | |
| SCHEMBL5168626 | 0.89 | STS (1.00) | STSCA2CA9CA1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119701013-A | Estrogen-beta-cyclodextrin inclusion compound, preparation method thereof and tablets | 浙江仙琚制药股份有限公司 | 2025-03-28 | — | — | CN | claimed |
| EP-2062569-B1 | Vaginal delivery system | BAYER OY (FI) | 2011-05-11 | — | — | EP | claimed |
| US-20110097405-A1 | ESTRADIOL-CONTAINING DRUG DELIVERY SYSTEM | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2011-04-28 | — | — | US | claimed |
| EP-2249803-A2 | ESTRADIOL-CONTAINING DRUG DELIVERY SYSTEM | Bayer Schering Pharma Aktiengesellschaft (DE) | 2010-11-17 | — | — | EP | claimed |
| US-20100285097-A1 | VAGINAL DELIVERY SYSTEM | BAYER OY (FI) | 2010-11-11 | — | — | US | claimed |
| EP-2227220-A1 | VAGINAL DELIVERY SYSTEM | Bayer Schering Pharma Oy (FI) | 2010-09-15 | — | — | EP | claimed |
| WO-2009101021-A2 | ESTRADIOL-CONTAINING DRUG DELIVERY SYSTEM | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-08-20 | — | — | WO | claimed |
| US-20090142313-A1 | VAGINAL DELIVERY SYSTEM | BAYER SCHERING PHARMA OY (FI) | 2009-06-04 | — | — | US | claimed |
| WO-2009066006-A1 | VAGINAL DELIVERY SYSTEM | BAYER SCHERING PHARMA OY (FI) | 2009-05-28 | — | — | WO | claimed |
| EP-2062569-A1 | Vaginal delivery system | Bayer Schering Pharma Oy (FI) | 2009-05-27 | — | — | EP | claimed |
| EP-1772462-A2 | Steroid sulfamates, method for the production and use thereof | Sterix Limited (GB) | 2007-04-11 | — | — | EP | claimed |
| US-7053077-B1 | such as estrone sulfamate and/or estradiol sulfamate for oral administration or for use in intrauterine releasing system (IUD) | SCHERING AG (DE) | 2006-05-30 | — | — | US | claimed |
| US-20060111334-A1 | Oral solid dosage forms containing a low dose of estradiol | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2006-05-25 | — | — | US | claimed |
| WO-2006048261-A2 | ORAL SOLID DOSAGE FORMS CONTAINING A LOW DOSE OF ESTRADIOL | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2006-05-11 | — | — | WO | claimed |
| EP-1100509-B1 | USE OF BIOGENIC ESTROGEN SULFAMATES FOR HORMONE REPLACEMENT THERAPY | SCHERING AG (DE) | 2005-04-06 | — | — | EP | claimed |
| US-6869941-B2 | Combination of drospirenone and an estrogen sulphamate for HRT | SCHERING AG (DE) | 2005-03-22 | — | — | US | claimed |
| EP-1406634-A1 | COMBINATION OF DROSPIRENONE AND AN ESTROGEN SULPHAMATE FOR HRT | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-04-14 | — | — | EP | claimed |
| US-20030050289-A1 | Combination of drospirenone and an estrogen sulphamate for HRT | SCHERING AG (DE) | 2003-03-13 | — | — | US | claimed |
| WO-2003006027-A1 | COMBINATION OF DROSPIRENONE AND AN ESTROGEN SULPHAMATE FOR HRT | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-01-23 | — | — | WO | claimed |
| US-6339079-B1 | FOR THERAPY AND DIAGNOSIS OF ESTROGEN-DEPENDENT TUMORS | ID PHARMA GMBH (DE) | 2002-01-15 | — | — | US | claimed |